Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.
Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.
Acri.Tec generated sales revenues in the 2006 financial year of 15.4 million. The enterprise value calculated for the company totals 24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price.
Carl Zeiss will acquire all Acri.Tec shares against a cash settlement. The transaction is subject to approval by the German anti-trust authority but, once this approval has been given, the acquisition is expected to be closed during October 2007.